Some Things that You Should Know Regarding Bipolar Depression
You must understand that bipolar disorder is a kind of condition which affects all types of individuals. Children and adults are affected by this condition. This is one fact that you must understand. The women are going to suffer the most from such type of depression which is called bipolar depression disorder.
This isn’t very strange or far-fetched in any case, since even when the women would suffer from such regular bipolar kind of depression or the depressive disorder, they would often spend more time depressed than they do being manic. Not just women are depressive but the men would also get affected by such kind of condition.
Such bipolar kind of disorder is called manic depression since such is one mental condition in which you would interchange often between the phases of mania as well as depression. If you are suffering from bipolar depression, you won’t be spending as much time being manic as you would spend being depressed.
Such kind of depression is a form of disorder and you must understand that it is easy to mistakenly diagnose as bipolar disorder because of the sameness of these symptoms. Because of such, the doctor must keep you around for such a long time when they would try to diagnose the condition you have. It certainly won’t be flattering to either of you when you are treated for a wrong thing.
The bipolar affective disorder is simply another name for such bipolar disorder or the manic-depressive illness. But, you don’t like to mistake this for bipolar depression disorder. This is closely related with the symptoms of the depressive phase of the bipolar disorder but just a few of the mania.
The monotherapy trials against the placebo continue to be the gold-standard design when it comes to determining the efficacy in bipolar depression. If the efficacy would get proven as monotherapy, those new compounds can be tested in the adjunctive-medication placebo-controlled trials. The younger adults, without the need for the long-term medication can be fit for the clinical trials which need placebo-controls. The switch to mania or such hypomania can be a consequence of the active treatment for such bipolar depression.
Some medications like the tricyclic antidepressants and the venlafaxine can be more likely to prove switch as compared to the others but the increased rate of the switch can’t be seen until about 10 weeks of treatment. Thus, the 12-week trials against placebo are needed to determine the risk of switch and establish the continuing effects. You should know that careful assessment at 6-8 weeks are required to make sure that the patients who fail to respond won’t continue in the study for the unacceptable periods of time.